Related Experiment Video
Updated: May 27, 2026

Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland
Published on: June 7, 2019
Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex
Bogyou Kim1, Hye Jin Nam, Ki Eun Pyo
1Department of Biological Sciences, Creative Research Initiative Center for Chromatin Dynamics, Seoul National University, Seoul 151-742, South Korea.
Abstract:
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis without affecting primary tumorigenesis. The regulatory mechanism of BRMS1 at the protein level has not been revealed until recently. Here, we found that cullin 3 (Cul3), a component of E3 ubiquitin ligase, is a new binding partner of BRMS1 and the interaction between BRMS1 and Cul3 is mediated by the SPOP adaptor protein. Intriguingly, BRMS1 turns out to be a potent substrate that is ubiquitinated by the Cul3-SPOP complex. Knockdown of SPOP increases the level of BRMS1 protein and represses the expression of BRMS1 repressive target genes such as OPN and uPA in breast cancer cells. These results suggest that the novel regulatory mechanism of BRMS1 by Cul3-SPOP complex is important for breast cancer progression.
Insights
Breast cancer metastasis suppressor 1 (BRMS1) protein levels are regulated by the cullin 3-SPOP complex. This novel mechanism impacts breast cancer progression by controlling metastasis-associated genes.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Breast cancer metastasis suppressor 1 (BRMS1) inhibits cancer spread but its protein-level regulation remains unclear.
- Understanding BRMS1 regulation is crucial for developing targeted breast cancer therapies.
Purpose of the Study:
- To elucidate the post-translational regulatory mechanisms governing BRMS1 protein stability.
- To identify novel binding partners and E3 ubiquitin ligase complexes involved in BRMS1 regulation.
Main Methods:
- Co-immunoprecipitation assays to identify BRMS1 binding partners.
- Ubiquitination assays to assess BRMS1 as a substrate.
- RNA interference (RNAi) to knock down SPOP expression.
- Quantitative real-time PCR to analyze target gene expression.
Main Results:
- Cullin 3 (Cul3) was identified as a novel binding partner of BRMS1, with the SPOP adaptor protein mediating the interaction.
- BRMS1 was found to be a substrate for ubiquitination by the Cul3-SPOP E3 ubiquitin ligase complex.
- SPOP knockdown led to increased BRMS1 protein levels.
- Reduced expression of BRMS1-repressed genes (e.g., Osteopontin (OPN) and Urokinase Plasminogen Activator (uPA)) was observed in breast cancer cells with SPOP knockdown.
Conclusions:
- The Cul3-SPOP complex regulates BRMS1 protein stability through ubiquitination.
- This novel regulatory pathway plays a significant role in breast cancer progression.
- Targeting the Cul3-SPOP-BRMS1 axis may offer new therapeutic strategies for breast cancer metastasis.
More Related Videos
09:00Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Anaphase Promoting Complex
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...